Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023)
VANCOUVER, British Columbia, Dec. 02, 2023 -- Xenon Pharmaceuticals Inc. , a neurology-focused biopharmaceutical company, today announced it will provide updates on its neurology programs at the...
Source: marketscreener.com